Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin. - Wikidata - awgldk - TriplyDB

Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.

Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.

http://www.wikidata.org/entity/Q37286356

about

C-galactosylceramide: Synthesis and immunology Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates Current efforts and future prospects in the development of live mycobacteria as vaccines Antigen-specific human NKT cells from tuberculosis patients produce IL-21 to help B cells for the production of immunoglobulins Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.A rapid fluorescence-based assay for classification of iNKT cell activating glycolipids.Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.Enhanced priming of adaptive immunity by Mycobacterium smegmatis mutants with high-level protein secretion.Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy Protective effect of a lipid-based preparation from Mycobacterium smegmatis in a murine model of progressive pulmonary tuberculosis.Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis Retinoic acid and α-galactosylceramide differentially regulate B cell activation in vitro and augment antibody production in vivo iNKT cell production of GM-CSF controls Mycobacterium tuberculosis.Simplexide induces CD1d-dependent cytokine and chemokine production from human monocytes Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect.Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis.NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis.Current and novel approaches to vaccine development against tuberculosis.HIV-1 and the immune response to TB.Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens A double-edged sword: the role of NKT cells in malaria and HIV infection and immunity.Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.Role of type 1 natural killer T cells in pulmonary immunity.In search of a new paradigm for protective immunity to TB Optimizing NKT cell ligands as vaccine adjuvants Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.Small-Molecule Carbohydrate-Based Immunostimulants.Glycolipid activators of invariant NKT cells as vaccine adjuvants.Mycobacterium tuberculosis-specific memory NKT cells in patients with tuberculous pleurisy.Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.Quantitative and qualitative iNKT repertoire associations with disease susceptibility and outcome in macaque tuberculosis infection.A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice.Successes and failures in human tuberculosis vaccine development.Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells.Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect.

P2860

Q24625835-BE57EF24-AA9C-403F-ACAD-DFE5F8D71D41 Q26748456-6D39D6E7-9325-47C0-A5ED-B0916F19B230 Q27303293-7AB765F1-1999-456E-8617-BEA1368D244D Q28087077-F885ACFA-C506-4D90-88AC-F360813D0010 Q28386271-3B79F76F-F7A6-421E-805B-DB03F523FA32 Q28543248-958670B5-1514-4A62-8EA6-4B5DBB47AD69 Q33724575-6AFE9181-A9BE-4C8B-8C11-B00AB9285667 Q33852300-1D0066E7-04F4-47C3-BF60-6BA96890DB13 Q34172161-CF29B9DE-93F1-404F-AE5B-572382F86150 Q34334036-9C8A07BD-D7C8-4FF7-8CEC-7C356626622C Q34499626-C401EA20-FE51-4DE2-8F93-8545762E466D Q34762605-375C6817-0DEF-4393-95D8-0B07D31B9B74 Q35063750-DB2535FF-FF76-4A24-B0C7-3AE3180757A7 Q35066481-1BA9CE0A-5A53-45E6-BFE4-02C1342FEB2D Q35082184-7D61B606-FD93-4610-ABC3-A8F57B6C5AB5 Q35414072-FA48806B-8CFB-4394-B2F4-2016ECB3D7A4 Q35589680-07D53F8A-03AC-4A83-9689-61682C573C0B Q36018172-C8DE567E-F9EB-45F8-BF0C-AE71D3188EB7 Q36031556-3FEA9AED-FE69-48FE-B469-C274CB8E86DC Q36038717-FCD1165C-C7EE-4546-AA29-0AFF2CCE3FC3 Q36083904-C6B48070-2B51-40BC-9CDB-64BC33E58FEB Q36449189-2760860A-4CAB-4179-91DA-63BAF84F2A6E Q36815449-120BEF20-3157-4178-9BE5-F6CD7522D6D7 Q36909492-E2F61BEC-9174-4F54-947A-8321D5E99751 Q37491277-4C107742-719A-49E9-B8A1-4791AEBDF42C Q37644961-4459B59F-D37B-4380-BB3C-7ECFBABEB69B Q37822744-2878C9F7-72E4-46EC-83B0-4BC7DC533F00 Q38150638-83EB4AC9-2CAB-4111-882D-3BF65D54260F Q38192925-0E40BF7A-9AE2-45E2-A316-CD1B7D024804 Q38206819-388484DB-D23C-4B5E-A9C5-68E82DB606F6 Q38254986-0A1FBCAF-91A5-412C-86B2-89BBEAF46DD0 Q38844616-73CD2B0B-27A2-4CB9-A720-3E475FA52CA2 Q38885794-99C9B35B-A772-4E5B-8B59-BDD942D4A8E4 Q39178060-8F9259C6-54C4-40AA-A3E3-E5FFA25D4F36 Q39955940-7FA37D0A-D5A2-49C0-8627-A09972AE465C Q40174043-EC522482-8AC4-49AE-B7DB-D38FF5EDEC49 Q40500189-F49811DC-1B9A-4C1F-9F68-7522F31E9284 Q41996442-552413D5-1309-47B1-9119-0C8F9367FD11 Q44622580-0C756A03-D229-4F43-9EDD-4163F307F425 Q47993724-282CC623-3B9E-40E0-8E5D-11965CB61AA5

P2860

Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.

http://www.wikidata.org/entity/Q37286356

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Incorporation of NKT cell-acti ...... ovis bacillus Calmette-Guerin.

@en

Incorporation of NKT cell-acti ...... ovis bacillus Calmette-Guerin.

@nl

type

label

Incorporation of NKT cell-acti ...... ovis bacillus Calmette-Guerin.

@en

Incorporation of NKT cell-acti ...... ovis bacillus Calmette-Guerin.

@nl

prefLabel

Incorporation of NKT cell-acti ...... ovis bacillus Calmette-Guerin.

@en

Incorporation of NKT cell-acti ...... ovis bacillus Calmette-Guerin.

@nl

P1433

Q37286356-C26A2145-86CA-4302-81B0-ADD09EC3083E

P1476

Q37286356-6F3EDBAB-EE65-40E8-9EC7-29DB661DB8D4

P2093

Q37286356-19C3B4ED-2909-456A-829F-7961F7E54F14

Q37286356-1A0E7CCA-6FD8-4DA0-996E-FD8888BF7676

Q37286356-69DBCD61-736B-4873-9540-92E223FEDDCE

Q37286356-99BC1FB0-2218-4F55-86A4-C935922DE980

Q37286356-9F748CA9-3040-4881-9667-B877928521E3

Q37286356-B4CF2278-69C7-4C01-9AE2-2CF9D104C767

Q37286356-C2AE8C79-3F0C-4E15-8447-F81A82DAA39B

Q37286356-F503C126-ABFA-4B07-B665-04E78D216E68

P2860

Q37286356-01DFC2BA-7544-4CCB-8C46-D62B895B3E41

Q37286356-0930A741-2B04-4A61-8EB4-AB6EA3038F5B

Q37286356-168DAC44-FE18-4C75-8F33-161E8FFF6897

Q37286356-18C9548D-F35C-4485-B807-598D440C4B4A

Q37286356-1A07CB1D-FC5B-4685-8B54-C53AAF067E3A

Q37286356-1ADD0E7B-AFD9-4404-AD3C-72481349298E

Q37286356-1BE1B029-4346-43FB-9EF4-E7ADB245C334

Q37286356-1E58E5F2-DFDA-4DAB-9DBE-3BCE9C1D83AC

Q37286356-2117BF0F-A7E5-4A0C-8274-DC22CB1CC70C

Q37286356-3B81FEB0-5B71-4726-A0F6-E35C9A103579

P304

Q37286356-0E3BE835-0A4E-4814-96DF-43BE6D14C7BB

P31

Q37286356-80D7F48F-4A5F-4A7E-B341-9DE15D729D14

P356

Q37286356-879CEB86-93A2-4836-831E-406DDE5094B3

P407

Q37286356-29C8725F-7785-45DE-975B-43AF0E9299C9

P433

Q37286356-5565B234-4E72-4E31-B754-F9CCD91A84DD

P478

Q37286356-FA62A641-5378-49DD-BC55-C08ECB3AEA0B

P50

Q37286356-600FC35C-70CA-4697-A705-E824793E3EED

Q37286356-637E98D5-6C22-46F1-8BEB-BD5496734B68

P577

Q37286356-5405BF04-86E2-4019-AA43-2FFD853BAC78

P5875

Q37286356-EBFFE4FF-C59C-49AC-8FB9-849D4A783F5C

P698

Q37286356-52972B3B-890F-456A-837C-F04BDB96F420

P932

Q37286356-921D8F41-BD23-4372-A73B-6B015931B9A1

P356

JIMMUNOL.0900858

P1433

Journal of Immunology

P1476

Incorporation of NKT cell-acti ...... ovis bacillus Calmette-Guerin.

@en

P2093

Andres Baena

http://www.w3.org/2001/XMLSchema#string

Faye Reddington

http://www.w3.org/2001/XMLSchema#string

Gabriel Bricard

http://www.w3.org/2001/XMLSchema#string

Jin S Im

http://www.w3.org/2001/XMLSchema#string

John Chan

http://www.w3.org/2001/XMLSchema#string

Manjunatha M Venkataswamy

http://www.w3.org/2001/XMLSchema#string

Michael F Goldberg

http://www.w3.org/2001/XMLSchema#string

William R Jacobs

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

The biology of NKT cells

Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule

Immunology of tuberculosis

Differential antigen processing by dendritic cell subsets in vivo

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria.

P304

1644-1656

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0900858

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

183

http://www.w3.org/2001/XMLSchema#string

P50

Steven A Porcelli

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26683999

http://www.w3.org/2001/XMLSchema#string

P698

19620317

http://www.w3.org/2001/XMLSchema#string

P932

2719834

http://www.w3.org/2001/XMLSchema#string